Inactivation of Palb2 gene leads to mesoderm differentiation defect and early embryonic lethality in mice

Pia Rantakari1, Jenni Nikkilä, Heli Jokela

  • 1Department of Physiology, Turku Center for Disease Modeling, Institute of Biomedicine, University of Turku, FIN-20520 Turku, Finland.

Insights

Loss of the PALB2 gene causes embryonic lethality in mice, similar to BRCA1 and BRCA2. This highlights PALB2's crucial role in DNA repair and tumor suppression.

Area of Science:

  • Genetics
  • Molecular Biology
  • Cancer Research

Background:

  • Mutations in the tumor suppressor gene PALB2 are linked to hereditary breast and other cancers.
  • Understanding the in vivo function of PALB2 is crucial for comprehending its role in cancer predisposition.

Purpose of the Study:

  • To characterize the in vivo phenotype of mice deficient in Palb2.
  • To investigate the functional relationship between PALB2, BRCA1, and BRCA2 in DNA damage response.

Main Methods:

  • Generation and analysis of Palb2 heterozygous ((+/-)) and homozygous ((-/-))) knockout mice.
  • Phenotypic characterization of mutant embryos and blastocysts, including developmental assessments and gene expression analysis.

Main Results:

  • Palb2((+/-)) mice are normal and do not develop tumors by 8 months.
  • Homozygous Palb2((-/-)) mice exhibit embryonic lethality by E9.5, with smaller, developmentally retarded embryos showing defective mesoderm differentiation.
  • Palb2((-/-)) embryos display increased p21 expression and blastocysts show in vitro growth defects.

Conclusions:

  • The phenotype of Palb2((-/-)) mice closely resembles that of Brca1 and Brca2 knockout mice, supporting a functional link.
  • PALB2 is essential for embryonic development, likely by facilitating the interaction and communication between BRCA1 and BRCA2.
  • These findings underscore PALB2's critical role in homologous recombination and DNA damage response, similar to BRCA1 and BRCA2.